Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri  – Russia, 2019-10-28 11:13 (2030 d 17:12 ago) – Posting: # 20727
Views: 5,824
(edited on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
99 visitors (0 registered, 99 guests [including 10 identified bots]).
Forum time: 05:25 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5